Advancing synthetic biology with engineered chemically inducible gene regulatory systems.

Engineered chemically inducible gene regulatory systems advance synthetic biology by enabling precise, dynamic, and orthogonal control of gene expression using inducible promoters responsive to chemical signals.

• Why it matters: The field needs promoter-centered, controllable regulation that is reversible, dose-dependent, and orthogonal, while overcoming limits like inducer permeability, cross-talk, and scalability.
• What they did: The review synthesizes progress combining promoter remodeling, transcription factor engineering, computational design, high-throughput screening, and direct-acting promoter screening, emphasizing five design principles.
• The result: Emerging approaches—AI-driven promoter prediction, G-quadruplex DNA switches, and engineered receptor pathways—support applications from metabolic optimization to gene therapy and programmable circuits, with future gains expected via trace-free inducers and autonomous industrial regulation.

AI summary of the abstract · may contain errors · not medical advice · read the paper.